Skip to main content
. 2011 Jun;85(12):6024–6037. doi: 10.1128/JVI.00131-11

Fig. 6.

Fig. 6.

Sensitivity of HIV-1 gp160s to maraviroc. Patient/tissue-specific env+ pseudovirions were tested for sensitivity to entry inhibition by maraviroc.

HHS Vulnerability Disclosure